Individualizing Obesity Treatment

In the third video of the series, PA Ledyi Ballesteros explores how to individualize obesity treatment by evaluating comorbidities, contraindications, patient preferences, and financial considerations. Using a practical patient case, she illustrates how treatment goals, patient conditions, and access can shape medication selection and overall care planning.

PA Ballesteros also highlights the importance of building flexible treatment strategies, including backup options when coverage, tolerability, or response become barriers. Clinicians will gain practical insight into matching obesity therapies to each patient’s clinical profile while supporting realistic, patient-centered decision-making.

Key Takeaways:

  1. Consider weight reduction needs as well as comorbidities and patient preferences when suggesting medications.
  2. If one medication doesn’t work for any reason, there may be others that will.

Previous VideoNext Video

Speaker

Click on the photo below to learn more about the speaker.

References and Additional Resources:

Wegovy (Semaglutide). Package insert. Novo Nordisk; 2026. https://www.novo-pi.com/wegovy.pdf

Squire P, Naude J, Zentner A, Bittman J, Khan N. Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis. BMJ Open. 2025;15(1):e089477. https://pmc.ncbi.nlm.nih.gov/articles/PMC11751938/

Supported by